• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源 UDP-葡糖醛酸基转移酶在昆虫细胞中的表达:活性和非活性重组蛋白的比例,以及 C 末端组氨酸标签对葡糖醛酸化动力学的影响。

Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.

机构信息

Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, Finland.

出版信息

Drug Metab Dispos. 2012 Oct;40(10):1935-44. doi: 10.1124/dmd.112.046086. Epub 2012 Jul 10.

DOI:10.1124/dmd.112.046086
PMID:22782802
Abstract

Many laboratories use recombinant UDP-glucuronosyltransferases (UGTs), expressed in baculovirus-infected insect cells, for drug glucuronidation studies. We have infected Sf9 insect cells with increasing amounts of recombinant baculovirus, encoding either UGT1A9 or UGT2B7, and measured both glucuronidation activity and immunodetectable UGT in the resulting cell homogenates. The correlation between glucuronidation rates and degree of infection followed different trends, depending on whether activity was the actual activity measured or was corrected for UGT expression level. Above a certain low level of infection, further increases in infection ratios led to a large decline in normalized activity, presumably due to the presence of full-length but inactive enzyme in the sample. Because immunodetection does not distinguish between active and inactive UGT, comparison of normalized activity between different batches of a recombinant UGT, mutants of a given UGT, or different UGTs is prone to large inaccuracies. Such inaccuracies could be reduced by lowering the degree of infection of the insect cells, in combination with careful monitoring of UGT expression. However, the latter requires suitable antibodies for comparing UGT expression levels among preparations, antibodies that are not always available. Poly-His (His-tag)-containing peptides, fused to the UGT C terminus, allow sensitive immunodetection of expressed enzymes with monoclonal antibodies. We have now carefully examined the effects of two such fusion peptides on enzyme kinetics. A minor increase in the K(m) values has been detected in the His-tagged UGTs, but no changes in parameters such as the kinetic model and the effects of albumin addition.

摘要

许多实验室使用重组 UDP-葡糖醛酸基转移酶(UGTs),在杆状病毒感染的昆虫细胞中表达,进行药物葡醛酸化研究。我们用编码 UGT1A9 或 UGT2B7 的重组杆状病毒感染 Sf9 昆虫细胞,测量所得细胞匀浆中的葡醛酸化活性和可免疫检测的 UGT。葡醛酸化速率与感染程度之间的相关性呈现出不同的趋势,具体取决于所测活性是实际活性还是校正了 UGT 表达水平。在一定的低感染水平之上,进一步增加感染比率会导致归一化活性的大幅下降,这可能是由于样品中存在全长但无活性的酶。因为免疫检测无法区分有活性和无活性的 UGT,所以在比较不同批次的重组 UGT、特定 UGT 的突变体或不同 UGT 之间的归一化活性时,很容易出现较大的误差。通过降低昆虫细胞的感染程度,并结合对 UGT 表达的仔细监测,可以减少这种误差。然而,后者需要合适的抗体来比较制剂之间的 UGT 表达水平,而这些抗体并非总是可用的。含有多组氨酸(His 标签)的肽与 UGT C 端融合,允许使用单克隆抗体对表达的酶进行敏感的免疫检测。我们现在已经仔细研究了这两种融合肽对酶动力学的影响。在 His 标记的 UGT 中检测到了 K(m)值的轻微增加,但参数如动力学模型和白蛋白添加的影响没有变化。

相似文献

1
Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.人源 UDP-葡糖醛酸基转移酶在昆虫细胞中的表达:活性和非活性重组蛋白的比例,以及 C 末端组氨酸标签对葡糖醛酸化动力学的影响。
Drug Metab Dispos. 2012 Oct;40(10):1935-44. doi: 10.1124/dmd.112.046086. Epub 2012 Jul 10.
2
Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.牛血清白蛋白降低人 UDP-葡糖醛酸基转移酶 1A9 和 2B7 的 Km 值,并增加 UGT1A9 的 Vmax 值。
Drug Metab Dispos. 2011 Nov;39(11):2117-29. doi: 10.1124/dmd.111.041418. Epub 2011 Aug 19.
3
Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.鉴定人肝和肠中负责达比加群(一种口服因子 Xa 抑制剂)葡萄糖醛酸化的 UDP-葡萄糖醛酸转移酶。
Drug Metab Dispos. 2012 Feb;40(2):276-82. doi: 10.1124/dmd.111.042614. Epub 2011 Oct 26.
4
Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7.人肝微粒体和表达的尿苷二磷酸葡萄糖醛酸基转移酶对姜辣素的区域选择性葡萄糖醛酸化:UGT1A9和UGT2B7的反应动力学及活性相关性分析
J Pharm Pharmacol. 2015 Apr;67(4):583-96. doi: 10.1111/jphp.12351. Epub 2014 Dec 10.
5
Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.重组人尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的表达与特性。UGT1A9比其他UGTs对去污剂抑制更具抗性,并被纯化为一种活性二聚体酶。
J Biol Chem. 2003 Feb 7;278(6):3536-44. doi: 10.1074/jbc.M206136200. Epub 2002 Nov 14.
6
How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?高度同源的 UDP-葡糖醛酸基转移酶(UGT)1A9 和 UGT1A10 之间的活性差异有多大,是由多少个氨基酸造成的?
Drug Metab Dispos. 2010 Apr;38(4):687-96. doi: 10.1124/dmd.109.031229. Epub 2010 Jan 20.
7
Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.依达拉奉在人肝微粒体和肾微粒体中的葡萄糖醛酸化:双相动力学及 UGT1A9 为主要的 UDP-葡萄糖醛酸基转移酶同工酶的鉴定。
Drug Metab Dispos. 2012 Apr;40(4):734-41. doi: 10.1124/dmd.111.043356. Epub 2012 Jan 11.
8
The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.“白蛋白效应”与药物葡糖醛酸化:牛血清白蛋白和无脂肪酸人血清白蛋白增强尿苷二磷酸葡糖醛酸基转移酶(UGT)1A9底物的葡糖醛酸化作用,但不影响UGT1A1和UGT1A6的活性。
Drug Metab Dispos. 2008 Jun;36(6):1056-62. doi: 10.1124/dmd.108.021105. Epub 2008 Mar 24.
9
Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.涉及氟哌啶醇葡萄糖醛酸化的人 UDP-葡糖醛酸基转移酶同工酶及其贡献的定量估计。
Drug Metab Dispos. 2012 Feb;40(2):240-8. doi: 10.1124/dmd.111.042150. Epub 2011 Oct 25.
10
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.尿苷二磷酸葡萄糖醛酸基转移酶2B7在人肝脏中对消旋氟比洛芬葡萄糖醛酸化的主要贡献。
Drug Metab Dispos. 2007 Jul;35(7):1182-7. doi: 10.1124/dmd.107.015347. Epub 2007 Apr 19.

引用本文的文献

1
Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs.使用重组 UGT 预测葡萄糖醛酸化介导的药物清除率时,相对活性与相对表达因子(RAF 与 REF)的比较。
Pharm Res. 2024 Aug;41(8):1621-1630. doi: 10.1007/s11095-024-03750-x. Epub 2024 Aug 6.
2
Integrate thermostabilized fusion protein apocytochrome RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7.整合热稳定融合蛋白脱辅基细胞色素RIL和N-糖基化突变:人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)2B7异源表达的新方法。
Front Pharmacol. 2022 Aug 12;13:965038. doi: 10.3389/fphar.2022.965038. eCollection 2022.
3
Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4.
杆状病毒-哺乳动物细胞表达系统在药物代谢酶表达中的应用:以细胞色素P450 3A4为重点的感染优化
Front Pharmacol. 2022 Feb 22;13:832931. doi: 10.3389/fphar.2022.832931. eCollection 2022.
4
Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的酶动力学。
Methods Mol Biol. 2021;2342:301-338. doi: 10.1007/978-1-0716-1554-6_12.
5
Oligomerization and Catalytic Parameters of Human UDP-Glucuronosyltransferase 1A10: Expression and Characterization of the Recombinant Protein.人 UDP-葡萄糖醛酸基转移酶 1A10 的寡聚化和催化参数:重组蛋白的表达和特性。
Drug Metab Dispos. 2018 Oct;46(10):1446-1452. doi: 10.1124/dmd.118.082495. Epub 2018 Aug 15.
6
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.开启健康与疾病中体外表型研究的肾脏入路关键:第二部分:机制模型与体外表型研究。
AAPS J. 2016 Sep;18(5):1082-1094. doi: 10.1208/s12248-016-9959-1. Epub 2016 Aug 9.
7
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.开启健康与疾病状态下体内外推断入口的肾脏研究钥匙:第一部分:体外系统与生理数据。
AAPS J. 2016 Sep;18(5):1067-1081. doi: 10.1208/s12248-016-9942-x. Epub 2016 Jun 30.
8
Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.肾药物和外源性物质葡萄糖醛酸化清除率的体外-体内外推(IV-IVE)的缩放因子。
Br J Clin Pharmacol. 2016 Jun;81(6):1153-64. doi: 10.1111/bcp.12889. Epub 2016 Mar 14.
9
The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.人 UDP-葡糖醛酸基转移酶 UGT2A1 和 UGT2A2 酶在胆汁酸的葡糖醛酸化中具有高度活性。
Drug Metab Dispos. 2013 Sep;41(9):1616-20. doi: 10.1124/dmd.113.052613. Epub 2013 Jun 11.
10
Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells.抗癌药物诱导黑色素瘤细胞中 UDP-葡糖醛酸基转移酶的重新表达。
PLoS One. 2012;7(10):e47696. doi: 10.1371/journal.pone.0047696. Epub 2012 Oct 22.